1-6 of 6
Sonia V. del Rincón
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer

Available to Purchase
Sathyen A. Prabhu, Omar Moussa, Christophe Gonçalves, Judith H. LaPierre, Hsiang Chou, Fan Huang, Vincent R. Richard, Pault Y. M. Ferruzo, Elizabeth M. Guettler, Isabel Soria-Bretones, Laura Kirby, Natascha Gagnon, Jie Su, Jennifer Silvester, Sai Sakktee Krisna, April A. N. Rose, Karen E. Sheppard, David W. Cescon, Frédérick A. Mallette, Rene P. Zahedi, Christoph H. Borchers, Sonia V. del Rincon, Wilson H. Miller, Jr
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (2): 192–204.
https://doi.org/10.1158/1535-7163.MCT-22-0092
Published: 01 February 2023
View articletitled, Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
Open the PDF for Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Acquired Resistance to EZH2 Inhibitor GSK343 Promotes the Differentiation of Human DLBCL Cell Lines toward an ABC-Like Phenotype

Available to Purchase
Samuel E.J. Preston, Audrey Emond, Filippa Pettersson, Daphné Dupéré-Richer, Madelyn Jean Abraham, Alberto Riva, Mena Kinal, Ryan N. Rys, Nathalie A. Johnson, Koren K. Mann, Sonia V. del Rincón, Jonathan D. Licht, Wilson H. Miller, Jr
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (4): 511–521.
https://doi.org/10.1158/1535-7163.MCT-21-0216
Published: 01 April 2022
View articletitled, Acquired Resistance to EZH2 Inhibitor GSK343 Promotes the Differentiation of Human DLBCL Cell Lines toward an ABC-Like Phenotype
Open the PDF for Acquired Resistance to EZH2 Inhibitor GSK343 Promotes the Differentiation of Human DLBCL Cell Lines toward an ABC-Like Phenotype in another window
Includes: Supplementary data
Journal Articles

Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition

Free
Tatiana Shorstova, Jie Su, Tiejun Zhao, Michael Dahabieh, Matthew Leibovitch, Mariana De Sa Tavares Russo, Daina Avizonis, Shivshankari Rajkumar, Ian R. Watson, Sonia V. del Rincón, Wilson H. Miller, Jr, William D. Foulkes, Michael Witcher
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2021) 20 (1): 64–75.
https://doi.org/10.1158/1535-7163.MCT-20-0259
Published: 05 January 2021
View articletitled, Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition
Open the PDF for Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition in another window
Includes: Supplementary data
Journal Articles

Abstract B235: The role of eIF4E in promoting melanoma cell proliferation and maintaining acquired resistance to vemurafenib in melanoma.

Free
Yao Zhan, Michael S. Dahabieh, Sonia V. del Rincon, Wilson H. Miller, Jr.
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): B235.
https://doi.org/10.1158/1535-7163.TARG-13-B235
Published: 01 November 2013
View articletitled, Abstract B235: The role of eIF4E in promoting melanoma cell proliferation and maintaining acquired resistance to vemurafenib in melanoma.
Journal Articles

Abstract A154: Inhibition of eIF4E with Ribavirin suppresses EMT and breast cancer invasiveness.

Free
Audrey Emond, Sonia V. Del Rincon, Bonnie Huor, Filippa Pettersson, Wilson H. Miller
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A154.
https://doi.org/10.1158/1535-7163.TARG-13-A154
Published: 01 November 2013
View articletitled, Abstract A154: Inhibition of eIF4E with Ribavirin suppresses EMT and breast cancer invasiveness.
Journal Articles

Expression of Leukemia-Associated Fusion Proteins Increases Sensitivity to Histone Deacetylase Inhibitor–Induced DNA Damage and Apoptosis

Free
Luca A. Petruccelli, Filippa Pettersson, Sonia V. del Rincón, Cynthia Guilbert, Jonathan D. Licht, Wilson H. Miller, Jr
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (8): 1591–1604.
https://doi.org/10.1158/1535-7163.MCT-12-1039
Published: 08 August 2013
View articletitled, Expression of Leukemia-Associated Fusion Proteins Increases Sensitivity to Histone Deacetylase Inhibitor–Induced DNA Damage and Apoptosis
Open the PDF for Expression of Leukemia-Associated Fusion Proteins Increases Sensitivity to Histone Deacetylase Inhibitor–Induced DNA Damage and Apoptosis in another window
Includes: Supplementary data